This section contains information intended for healthcare professionals. Please certify that you are a healthcare professional.

Please indicate your country of residence:

What language is your preference?

Show filters
Resources type
Filter by Resources type
Pathologies
Filter by Pathologies
Technologies
Filter by Technologies
Instruments
Filter by Instruments
61 result(s) found
Sort by:

To see or not A1c? HbA1c utilization in light of recent lab guidelines

Webinar
Jul. 12, 2024

Educational Webinar with Dr. Matthew C. Wagner

Unlocking the power of anti-MCV detection for early diagnosis of Rheumatoid Arthritis

Webinar
Jun. 07, 2024

Educational Webinar with Holger Bang, PhD & Roberto Fiorillo

May. 17, 2024 May. 20, 2024

Event
Ljubljana, Slovenia

14th International Congress on Autoimmunity 2024

Sebia booth #15

Learn more

Sebia receives U.S. FDA Clearance for the CAPILLARYS 3 DBS devices

Press Release
Apr. 11, 2024

The next generation instrument for screening hemoglobin disorders in newborns.

Apr. 18, 2024 Apr. 20, 2024

Event
Torino, Italy

European Myeloma Network Meeting – EMN 2024

Sebia booth: #9

Learn more

How External Quality Assessment supports quality improvement in laboratory hemoglobinopathy diagnosis

Webinar
Feb. 19, 2024

Educational Webinar with Dr. Barbara De la Salle

HYDRASYS 2 SCAN FOCUSING: Overview

Video
Feb. 13, 2024

Learn more about the HYDRASYS 2 SCAN FOCUSING for a fast and user-friendly gel electrophoresis processing.

Sebia launches M-inSight®, a test for monitoring multiple myeloma patients

Press Release
Dec. 04, 2023

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma